On April 25, 2024, Cuu Long Pharmaceuticals Joint Stock Company (Stock code: DCL) held its successful Annual General Meeting (AGM) via an online conference.
During taptap 188bet meeting, taptap 188bet AGM reviewed and approved taptap 188bet annual reports from taptap 188bet Board of Directors, taptap 188bet Executive Management Team, and taptap 188bet Supervisory Board for 2023, and discussed plans for 2024. taptap 188bet shareholders ratified taptap 188bet profit distribution for 2023, taptap 188bet financial statements for taptap 188bet same year, selected taptap 188bet auditing firm for 2024, and approved taptap 188bet remuneration reports for 2023 and plans for 2024 for board members and taptap 188bet supervisory board, among other authoritative documents.
Despite a challenging economic landscape in 2023, DCL remained committed to its strategic goals as per taptap 188bet OGSM framework, continuously innovating its product lines and investing in infrastructure and employee development. taptap 188bet audited consolidated financial statement for 2023 reported an increase in total assets from VND 2.105 trillion to over VND 2.277 trillion and a rise in shareholders’ equity from over VND 1.391 trillion to more than VND 1.450 trillion.
taptap 188bet year 2023 also marked significant recognitions for DCL, including being named among taptap 188bet Top 10 Leading Brands in Vietnam, earning a Top 10 spot for its Cefixime brand in product quality, and being listed among taptap 188bet Top 10 Best Workplaces in Vietnam within taptap 188bet Pharmaceutical and Medical Equipment sector.
During taptap 188bet AGM, there were also changes in taptap 188bet company’s leadership, with taptap 188bet dismissal and election of several board members and supervisory board members. Nguyen Ngoc Bich and Tuong Thi Thu Hanh were relieved from taptap 188bet Board of Directors, and Le Thi Thuong from taptap 188bet Supervisory Board. New elections were held, appointing Nguyen Ngoc Mai and Pham Van Ngoc to taptap 188bet Board of Directors, and Nguyen Thi Thu Huong to taptap 188bet Supervisory Board.
taptap 188bet AGM also approved taptap 188bet Business Plan for 2024, focusing on key areas:
taptap 188bet Board of Directors will enhance their guidance for taptap 188bet Executive Management Team to carry out key tasks and implement flexible operational strategies that are in line with market conditions. taptap 188bet focus will be on spearheading areas of operation:
Pharmaceuticals: For 2024, DCL plans to initiate projects like taptap 188bet “EU-GMP Standard Non-betalactam Factory Upgrade in Vinh Long” and taptap 188bet “FDA Standard Capsule Factory Upgrade.” taptap 188bet company aims to collaborate with international partners on a “Functional Food Production and Marketing” project and will proceed with taptap 188bet detailed assessment for taptap 188bet “EU-GMP Standard Pharmaceutical Factory” project in Long An province. This project, representing an investment of VND 1,035 billion over 50,000 m2, is expected to produce 1.6 billion pharmaceutical products annually once operational.
Medical Equipment Manufacturing, DCL is expanding its medical equipment manufacturing facilities in Vinh Long with an investment of approximately USD 15 million over 10,846.6 m2, planned in two phases. taptap 188bet first phase will have a capacity of 35 million products per month, and taptap 188bet second phase will support 20 million products per month. taptap 188bet factory is scheduled to be operational in Q3 2024, positioning DCL as a leader in pharmaceutical and medical equipment manufacturing in Vietnam.
Empty Capsule Production, in response to increasing demand in taptap 188bet pharmaceutical and functional food sectors, DCL is investing in taptap 188bet fifth expansion phase of its Capsule Plant. With an investment of VND 232.5 billion and a capacity of 2.8 billion capsules per year, taptap 188bet plant is expected to start operations in Q2 2024.
At taptap 188bet meeting, Mr. Luong Trong Hai, CEO of DCL, congratulated taptap 188bet success of taptap 188bet 2024 AGM. He highlighted taptap 188bet company’s proactive, stable, and adaptable approach amid economic challenges in 2023. He praised taptap 188bet collective achievements of taptap 188bet management team and staff, expressing optimism that in 2024, DCL would continue to excel in its business operations, striving to realize its vision of becoming taptap 188bet most highly-regarded pharmaceutical company in Vietnam, appreciated by patients, partners, and employees through innovative, accessible, and top-quality products and services.
